Alemasova E E, Naumenko K N, Moor N A, Lavrik O I
Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Novosibirsk, 630090, Russia.
Biochemistry (Mosc). 2017 Dec;82(12):1521-1528. doi: 10.1134/S0006297917120112.
Apurinic/apyrimidinic (AP) sites are among the most frequent DNA lesions. The first step in the AP site repair involves the magnesium-dependent enzyme AP endonuclease 1 (APE1) that catalyzes hydrolytic cleavage of the DNA phosphodiester bond at the 5' side of the AP site, thereby generating a single-strand DNA break flanked by the 3'-OH and 5'-deoxyribose phosphate (dRP) groups. Increased APE1 activity in cancer cells might correlate with tumor chemoresistance to DNA-damaging treatment. It has been previously shown that the multifunctional oncoprotein Y-box-binding protein 1 (YB-1) interacts with APE1 and inhibits APE1-catalyzed hydrolysis of AP sites in single-stranded DNAs. In this work, we demonstrated that YB-1 stabilizes the APE1 complex with double-stranded DNAs containing the AP sites and stimulates cleavage of these AP sites at low magnesium concentrations.
脱嘌呤/脱嘧啶(AP)位点是最常见的DNA损伤之一。AP位点修复的第一步涉及镁依赖性酶AP核酸内切酶1(APE1),它催化在AP位点5'侧的DNA磷酸二酯键的水解切割,从而产生一个由3'-OH和5'-脱氧核糖磷酸(dRP)基团侧翼的单链DNA断裂。癌细胞中APE1活性的增加可能与肿瘤对DNA损伤治疗的化学抗性相关。先前已经表明,多功能癌蛋白Y盒结合蛋白1(YB-1)与APE1相互作用并抑制APE1催化的单链DNA中AP位点的水解。在这项工作中,我们证明YB-1稳定了APE1与含有AP位点的双链DNA的复合物,并在低镁浓度下刺激这些AP位点的切割。